Work

Mechanistic and Structural Investigations into the Mode of Action of Allosteric HIV-1 Integrase Inhibitors

Year: 2019
Type: article
Abstract: Human immunodeficiency virus (HIV-1), the major cause of the acquired immunodeficiency syndrome (AIDS) epidemic, has led to the death of approximately 35 million people worldwide.While the search for a cure remains elusive, the administration of highly active anti-retroviral therapy (HAART) has changed the fate of a once deadly disease into a manageable chronic condition.HIV integrase (IN) is an essential viral protein for replication and has been extensively studied for both its functional biology and as a druggable target.Currently, there are four FDA approved IN inhibitors that inhibit the catalytic function of IN (termed INSTIs due to their activity against IN strand transfer).These front line therapy drugs exhibit highly potent activity; however, HIV has evolved to gain resistance to INSTIs requiring the further development of novel IN inhibitors with distinct mechanisms.This line of research has set the stage for my thesis work into a distinct class of IN inhibitors, termed allosteric IN inhibitors (ALLINIs).ALLINIs primary mode of action is through the promotion of aberrant or hyper-multimerization of IN in virions during the late stage.While IN organizes into catalytically active lower-order multimers, ALLINIs shifts the IN equilibrium to form higher-order inactive multimers during viral maturation.As a result, IN-viral RNA interactions are impaired leading to formation of eccentric virions Dedication This document is dedicated to my family, Subrahmanyeswara Rao, Bhavani and Sunil.vii
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W6983368264
FWCI: 0.351
Cites: 108
Cited by: 2
Related to: 10